Anti-tumor effects of the novel KIT mutant inhibitor M4205 in gastrointestinal stromal tumor (GIST) xenograft models

被引：0
|
作者：
De Sutter, L. [1 ]
Wozniak, A. [1 ]
Verreet, J. [1 ]
Vanleeuw, U. [1 ]
De Cock, L. [1 ]
Linde, N. [2 ]
Drechsler, C. [2 ]
Esdar, C. [2 ]
Sciot, R. [3 ]
Schoeffski, P. [4 ]
机构：
[1] Katholieke Univ Leuven, Lab Expt Oncol, Oncol, Leuven, Belgium
[2] Merck KGaA Germany, TIP Oncol, Darmstadt, Germany
[3] UZ Leuven, Univ Hosp Leuven, Pathol, Campus Gasthuisberg, Leuven, Belgium
[4] UZ Leuven, Univ Hosp Leuven, Med Oncol, Campus Gasthuisberg, Leuven, Belgium
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1617
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1514P
引用
收藏
页码：S1239 / S1239
页数：1
相关论文
共 50 条
  • [31] The analysis of status and clinical implication of KIT and PDGFRa mutations in gastrointestinal stromal tumor (GIST)
    Du, C., Sr.
    Zhou, Y.
    Shi, Y.
    Fu, H.
    Zhao, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Dedifferentiation in gastrointestinal stromal tumor (GIST) to an anaplastic KIT negative phenotype - A diagnostic pitfall
    Antonescu, C. R.
    Hornick, J. L.
    Nielsen, G. P.
    Mino-Kenudson, M.
    Wong, G.
    Corless, C.
    Fletcher, C. D. M.
    [J]. MODERN PATHOLOGY, 2007, 20 : 11A - 11A
  • [33] The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST)
    Du, Chun-Yan
    Shi, Ying-Qiang
    Zhou, Ye
    Fu, Hong
    Zhao, Guangfa
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (03) : 175 - 178
  • [34] The GIST of targeted cancer therapy:: A tumor (Gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571)
    DeMatteo, RP
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (09) : 831 - 839
  • [35] The GIST of targeted cancer therapy: A tumor (Gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571)
    Ronald P. DeMatteo
    [J]. Annals of Surgical Oncology, 2002, 9 : 831 - 839
  • [36] Potent anti-tumor activity of blocking stromal DII4 in ovarian xenograft models
    Kuhnert, Frank
    Chen, Guoying
    Thurston, Gavin
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [37] Ponatinib, a potent KIT inhibitor, suppresses the emergence of secondary resistance mutations in a gastrointestinal stromal tumor (GIST) model system
    Schrock, Alexa B.
    Chen, Tzu-Hsiu
    Rivera, Victor M.
    Gozgit, Joseph M.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [38] Anti-tumor activity of oncolytic reovirus against gastrointestinal stromal tumor cells
    Kubota, Eiji
    Inagaki, Yusuke
    Kataoka, Hiromi
    Aoyama, Mineyoshi
    Joh, Takashi
    [J]. CANCER SCIENCE, 2018, 109 : 700 - 700
  • [39] Anti-tumor efficacy of oncolytic reovirus against gastrointestinal stromal tumor cells
    Inagaki, Yusuke
    Kubota, Eiji
    Mori, Yoshinori
    Aoyama, Mineyoshi
    Kataoka, Hiromi
    Johnston, Randal N.
    Joh, Takashi
    [J]. ONCOTARGET, 2017, 8 (70) : 115632 - 115646
  • [40] GASTROINTESTINAL STROMAL TUMORS (GIST) AND SECOND MALIGNANCIES: A NOVEL "SENTINEL TUMOR"?
    Rodriquenz, M. G.
    Ricci, R.
    Iezzi, M.
    Martini, M.
    Basso, M.
    Dadduzio, V.
    Larocca, L. M.
    Barone, C.
    Cassano, A.
    [J]. ANNALS OF ONCOLOGY, 2014, 25
12345